Peri-mitral atrial flutter: personalized ablation strategy based on arrhythmogenic substrate

Abstract

The ablation strategy for PMAFL patients should be based on the arrhythmogenic substrate, but not the indiscriminate MI ablation. No-substrate PMAFLs during AF ablation could be monitored after cardioversion and might not need further ablation.